PERK — Perk Labs Cashflow Statement
0.000.00%
Last trade - 00:00- CA$5.01m
- CA$5.40m
- CA$0.03m
Annual cashflow statement for Perk Labs, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.
R2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13 | -8.08 | -4.49 | -1.49 | -3.38 |
| Depreciation | |||||
| Non-Cash Items | 0.569 | 1.21 | 2.15 | -0.792 | 1.22 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.3 | 1.65 | 0.034 | -0.023 | -0.094 |
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -14.3 | -4.8 | -2.23 | -2.21 | -2.16 |
| Capital Expenditures | -1.81 | -0.016 | 0 | -0.002 | -0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 1.09 | 0.63 | 0.269 | 0.805 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -1.81 | 1.08 | 0.63 | 0.267 | 0.804 |
| Financing Cash Flow Items | -0.78 | 0 | -0.124 | -0.126 | -0.019 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11.5 | 0 | 0.47 | 2.44 | 0.385 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.65 | -3.73 | -1.13 | 0.503 | -0.972 |